Literature DB >> 19539754

Abnormal glycosylation of dystroglycan in human genetic disease.

Jane E Hewitt1.   

Abstract

The dystroglycanopathies are a group of inherited muscular dystrophies that have a common underlying mechanism, hypoglycosylation of the extracellular receptor alpha-dystroglycan. Many of these disorders are also associated with defects in the central nervous system and the eye. Defects in alpha-dystroglycan may also play a role in cancer progression. This review discusses the six dystroglycanopathy genes identified so far, their known or proposed roles in dystroglycan glycosylation and their relevance to human disease, and some of animal models now available for the study of the dystroglycanopathies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19539754     DOI: 10.1016/j.bbadis.2009.06.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  35 in total

1.  Neurology of inherited glycosylation disorders.

Authors:  Hudson H Freeze; Erik A Eklund; Bobby G Ng; Marc C Patterson
Journal:  Lancet Neurol       Date:  2012-05       Impact factor: 44.182

2.  The role of dystroglycan in PDGF-BB-dependent migration of activated hepatic stellate cells/myofibroblasts.

Authors:  George John Kastanis; Zamira Hernandez-Nazara; Natalia Nieto; Ana Rosa Rincón-Sanchez; Anastas Popratiloff; Jose Alfredo Dominguez-Rosales; Carmen G Lechuga; Marcos Rojkind
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-09       Impact factor: 4.052

Review 3.  The o-mannosylation pathway: glycosyltransferases and proteins implicated in congenital muscular dystrophy.

Authors:  Lance Wells
Journal:  J Biol Chem       Date:  2013-01-17       Impact factor: 5.157

4.  Developmental increase in ecto-5'-nucleotidase activity overlaps with appearance of two immunologically distinct enzyme isoforms in rat hippocampal synaptic plasma membranes.

Authors:  Ivana Grkovic; Ivana Bjelobaba; Nadezda Nedeljkovic; Natasa Mitrovic; Dunja Drakulic; Milos Stanojlovic; Anica Horvat
Journal:  J Mol Neurosci       Date:  2014-02-22       Impact factor: 3.444

Review 5.  Protein O-mannosylation in animal development and physiology: from human disorders to Drosophila phenotypes.

Authors:  Naosuke Nakamura; Dmitry Lyalin; Vladislav M Panin
Journal:  Semin Cell Dev Biol       Date:  2010-04-01       Impact factor: 7.727

6.  Glycoproteomic characterization of recombinant mouse α-dystroglycan.

Authors:  Rebecca Harrison; Paul G Hitchen; Maria Panico; Howard R Morris; David Mekhaiel; Richard J Pleass; Anne Dell; Jane E Hewitt; Stuart M Haslam
Journal:  Glycobiology       Date:  2012-01-11       Impact factor: 4.313

7.  Analysis of phenotype, enzyme activity and genotype of Chinese patients with POMT1 mutation.

Authors:  Haipo Yang; Hiroshi Manya; Kazuhiro Kobayashi; Hui Jiao; Xiaona Fu; Jiangxi Xiao; Xiaoqing Li; Jingmin Wang; Yuwu Jiang; Tatsushi Toda; Tamao Endo; Xiru Wu; Hui Xiong
Journal:  J Hum Genet       Date:  2016-05-19       Impact factor: 3.172

8.  Adeno-associated viral-mediated LARGE gene therapy rescues the muscular dystrophic phenotype in mouse models of dystroglycanopathy.

Authors:  Miao Yu; Yonglin He; Kejian Wang; Peng Zhang; Shengle Zhang; Huaiyu Hu
Journal:  Hum Gene Ther       Date:  2013-03       Impact factor: 5.695

9.  Dystroglycan organizes axon guidance cue localization and axonal pathfinding.

Authors:  Kevin M Wright; Krissy A Lyon; Haiwen Leung; Daniel J Leahy; Le Ma; David D Ginty
Journal:  Neuron       Date:  2012-12-06       Impact factor: 17.173

10.  Novel POMGnT1 mutations cause muscle-eye-brain disease in Chinese patients.

Authors:  Hui Jiao; Hiroshi Manya; Shuo Wang; Yanzhi Zhang; Xiaoqing Li; Jiangxi Xiao; Yanling Yang; Kazuhiro Kobayashi; Tatsushi Toda; Tamao Endo; Xiru Wu; Hui Xiong
Journal:  Mol Genet Genomics       Date:  2013-05-21       Impact factor: 3.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.